{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:21:51Z","timestamp":1793744511464,"version":"4.6.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7673","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/nature24016","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T12:18:36Z","timestamp":1505823516000},"page":"523-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1179,"title":["ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy"],"prefix":"10.1038","volume":"549","author":[{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane Antony","family":"Liddelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea T.","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Baufeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Sutphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"McCue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Del-Aguila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Butovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben A.","family":"Barres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"BFnature24016_CR1","first-page":"a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman, D. M., Herz, J. & Bu, G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006312 (2012)","journal-title":"Perspect. Med."},{"key":"BFnature24016_CR2","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977\u20131981 (1993)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24016_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ana.21223","volume":"63","author":"KA Josephs","year":"2008","unstructured":"Josephs, K. A. et al. \u03b2-amyloid burden is not associated with rates of brain atrophy. Ann. Neurol. 63, 204\u2013212 (2008)","journal-title":"Ann. Neurol."},{"key":"BFnature24016_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T. & Hyman, B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42, 631\u2013639 (1992)","journal-title":"Neurology"},{"key":"BFnature24016_CR5","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams, D. R. et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-Parkinsonism from Richardson\u2019s syndrome. Brain 130, 1566\u20131576 (2007)","journal-title":"Brain"},{"key":"BFnature24016_CR6","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","volume":"91","author":"WJ Strittmatter","year":"1994","unstructured":"Strittmatter, W. J. et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 11183\u201311186 (1994)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24016_CR7","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht, W. J . et al. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24, 2527\u20132534 (2004)","journal-title":"J. Neurosci."},{"key":"BFnature24016_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","volume":"133","author":"Y Deming","year":"2017","unstructured":"Deming, Y. et al. Genome-wide association study identifies four novel loci associated with Alzheimer\u2019s endophenotypes and disease modifiers. Acta Neuropathol. 133, 839\u2013856 (2017)","journal-title":"Acta Neuropathol."},{"key":"BFnature24016_CR9","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/awx066","volume":"140","author":"A Mishra","year":"2017","unstructured":"Mishra, A. et al. Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia. Brain 140, 1437\u20131446 (2017)","journal-title":"Brain"},{"key":"BFnature24016_CR10","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/WNL.48.6.1526","volume":"48","author":"M Stevens","year":"1997","unstructured":"Stevens, M. et al. Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology 48, 1526\u20131529 (1997)","journal-title":"Neurology"},{"key":"BFnature24016_CR11","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1073\/pnas.0812697106","volume":"106","author":"F Agosta","year":"2009","unstructured":"Agosta, F. et al. Apolipoprotein E \u03b54 is associated with disease-specific effects on brain atrophy in Alzheimer\u2019s disease and frontotemporal dementia. Proc. Natl Acad. Sci. USA 106, 2018\u20132022 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24016_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neurobiolaging.2005.02.005","volume":"27","author":"S Engelborghs","year":"2006","unstructured":"Engelborghs, S . et al. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiol. Aging 27, 285\u2013292 (2006)","journal-title":"Neurobiol. Aging"},{"key":"BFnature24016_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007)","journal-title":"Neuron"},{"key":"BFnature24016_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-151101","volume":"51","author":"S Simonovitch","year":"2016","unstructured":"Simonovitch, S. et al. Impaired autophagy in APOE4 astrocytes. J. Alzheimers Dis. 51, 915\u2013927 (2016)","journal-title":"J. Alzheimers Dis."},{"key":"BFnature24016_CR15","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales, K. R. et al. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29, 6771\u20136779 (2009)","journal-title":"J. Neurosci."},{"key":"BFnature24016_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017)","journal-title":"Nature"},{"key":"BFnature24016_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153\u2013158 (2016)","journal-title":"Nature"},{"key":"BFnature24016_CR18","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek, M. P., Brown, C. M. & Colton, C. A. APOE genotype-specific differences in the innate immune response. Neurobiol. Aging 30, 1350\u20131360 (2009)","journal-title":"Neurobiol. Aging"},{"key":"BFnature24016_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","volume":"134","author":"SC Gale","year":"2014","unstructured":"Gale, S. C. et al. APO\u03b54 is associated with enhanced in vivo innate immune responses in human subjects. J. Allergy Clin. Immunol. 134, 127\u2013134 (2014)","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnature24016_CR20","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391\u20136410 (2012)","journal-title":"J. Neurosci."},{"key":"BFnature24016_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/exnr.1995.1093","volume":"136","author":"LA Farrer","year":"1995","unstructured":"Farrer, L. A. et al. Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp. Neurol. 136, 162\u2013170 (1995)","journal-title":"Exp. Neurol."},{"key":"BFnature24016_CR22","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang, Y. et al. Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl Acad. Sci. USA 98, 8838\u20138843 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature24016_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan, P. et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90, 724\u2013739 (2016)","journal-title":"Neuron"},{"key":"BFnature24016_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016)","journal-title":"J. Exp. Med."},{"key":"BFnature24016_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra, K. et al. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80, 402\u2013414 (2013)","journal-title":"Neuron"},{"key":"BFnature24016_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky, O. et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131\u2013143 (2014)","journal-title":"Nat. Neurosci."},{"key":"BFnature24016_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ana.24304","volume":"77","author":"O Butovsky","year":"2015","unstructured":"Butovsky, O. et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann. Neurol. 77, 75\u201399 (2015)","journal-title":"Ann. Neurol."},{"key":"BFnature24016_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00401-013-1080-2","volume":"125","author":"LT Grinberg","year":"2013","unstructured":"Grinberg, L. T. et al. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation. Acta Neuropathol. 125, 581\u2013593 (2013)","journal-title":"Acta Neuropathol."},{"key":"BFnature24016_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman, B. T. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 8, 1\u201313 (2012)","journal-title":"Alzheimers Dement."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature24016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature24016","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature24016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature24016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:05:29Z","timestamp":1684418729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature24016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":29,"journal-issue":{"issue":"7673","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFnature24016"],"URL":"https:\/\/doi.org\/10.1038\/nature24016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731245911.793537169","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"25 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.M.H. co-founded and is on the scientific advisory board of C<sub>2<\/sub>N Diagnostics. He consults for Genentech, AbbVie, Eli Lilly, Proclara, GlaxoSmithKline, and Denali. Washington University receives research grants to the laboratory of D.M.H. from C2N Diagnostics, Eli Lilly, AbbVie, and Denali.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}